MedPath

A study on pre-operative Misoprostol in reducing blood loss in total abdominal hysterectomy

Phase 4
Completed
Conditions
Health Condition 1: null- operative blood loss in total abdomonal hysterectomy (TAH)
Registration Number
CTRI/2011/091/000216
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Symptomatically women undergoing TAH for various benign gynaecological deseases

Exclusion Criteria

Any contraindication to misoprostol including mitral stenosis, glaucoma, diastolic blood pressure above 100mm of Hg, asthma, known allergic to prostaglandins

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath